Affinity improvement of a therapeutic antibody anti cancer drug trast uzumab by sequence based computational design

dc.contributor.guideBalkar, G
dc.coverage.spatialAffinity improvement of a therapeutic antibody anti cancer drug trast uzumab by sequence based computational design
dc.creator.researcherNataraj, B
dc.date.accessioned2023-05-04T09:57:52Z
dc.date.available2023-05-04T09:57:52Z
dc.date.awarded2022
dc.date.completed2022
dc.date.registered
dc.description.abstractArtificial intelligence (AI)/Machine learning (ML) has newlineapplications in almost all industries, from computer applications to newlinebiotechnology. One of the fascinating sciences is bioinformatics. newlineBioinformatics concentrates on applying computer science and techniques of newlineartificial intelligence in biology. With the ongoing COVID-19 pandemic and newlinethe recent Ebola outbreak, antibodies and vaccine development has become newlinethe need of the hour. The development of antibodies and vaccines is newlinesignificant to prevent the spread and control the outbreak. Nevertheless, newlinedesigning antibodies and developing the vaccine is very long and expensive, newlinecontaining lots of trials and errors methods. In addition, the most lifethreatening newlinedisease, such as cancer, has a whopping 10 million deaths in 2020 newlineaccording to the World Health Organization (WHO). More accurate and rapid newlineantibody identification and modification of existing antibodies through newlinecomputational approaches is the most pressing need for cancer. newlineThe newly approved antibody-based therapeutics are rapidly increasing newlinewith more than 100 new mAb Food and Drug Administration (FDA) newlineapprovals with multiple antibodies in clinical trials and patent filing stages. newlineThis is reflected in the market size for these molecules, estimated at USD130 newlinebillion in 2020 and projected to grow to USD223 billion by 2025. Most of newlinethese antibodies on the market were developed using costly and timeconsuming newlinetechniques, chiefly phage display or animal immunization newlineplatforms. With the maturity and increasing integration of computational newlineprotocols like machine learning, within pharma company pipelines, the time newlineand cost associated with therapeutic antibody development are expected to newlinedecrease. newline
dc.description.note
dc.format.accompanyingmaterialNone
dc.format.dimensions21cm.
dc.format.extentxxi,154p.
dc.identifier.urihttp://hdl.handle.net/10603/481291
dc.languageEnglish
dc.publisher.institutionFaculty of Technology
dc.publisher.placeChennai
dc.publisher.universityAnna University
dc.relationP.140-153
dc.rightsuniversity
dc.source.universityUniversity
dc.subject.keywordEngineering and Technology
dc.subject.keywordEngineering
dc.subject.keywordEngineering Chemical
dc.subject.keywordArtificial intelligence (AI)/Machine learning (ML)
dc.subject.keywordartificial intelligence in biology
dc.subject.keywordCOVID-19 pandemic and the recent Ebola
dc.titleAffinity improvement of a therapeutic antibody anti cancer drug trast uzumab by sequence based computational design
dc.title.alternative
dc.type.degreePh.D.

Files

Original bundle

Now showing 1 - 5 of 10
Loading...
Thumbnail Image
Name:
01_title.pdf
Size:
413.19 KB
Format:
Adobe Portable Document Format
Description:
Attached File
Loading...
Thumbnail Image
Name:
02_prelim pages.pdf
Size:
3.43 MB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
03_content.pdf
Size:
518.41 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
04_abstract.pdf
Size:
381.87 KB
Format:
Adobe Portable Document Format
Loading...
Thumbnail Image
Name:
05_chapter 1.pdf
Size:
842.43 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: